相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurotoxicity and apoptosis induced by pyrroloquinoline quinone and its ester derivative on primary cortical neurons
Ying Peng et al.
NEUROTOXICOLOGY (2020)
Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the blood-brain barrier
Camille Alam et al.
FASEB JOURNAL (2020)
Brain NMDA Receptors in Schizophrenia and Depression
Albert Adell
BIOMOLECULES (2020)
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
Christoph U. Correll et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation
Min Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Galphimia glauca and Natural Galphimines Block Schizophrenia-Like Symptoms Induced with Apomorphine and MK-801 in Mice
Mayra Alejandra Santillan-Urquiza et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings
Kenji Hashimoto
CURRENT PSYCHIATRY REPORTS (2019)
Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
Jeffrey A. Lieberman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice
Hiroshi Ueno et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Schizophrenia
Stephen R. Marder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Sex-specific transcriptional and proteomic signatures in schizophrenia
Jari Tiihonen et al.
NATURE COMMUNICATIONS (2019)
Glutamate hypothesis in schizophrenia
Yota Uno et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
Daniela Cadinu et al.
NEUROPHARMACOLOGY (2018)
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice
Zofia Rogoz et al.
PHARMACOLOGICAL REPORTS (2018)
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
Zahra Sepehrmanesh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3β/Akt signaling pathway in mouse
Xing-qin Zhou et al.
SCIENTIFIC REPORTS (2018)
Abnormalities in Prefrontal Cortical Gene Expression Profiles Relevant to Schizophrenia in MK-801-Exposed C57BL/6 Mice
Jialu Zhao et al.
NEUROSCIENCE (2018)
How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review
Bettina Lange et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
Taro Kishi et al.
PSYCHOPHARMACOLOGY (2017)
Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC)No 258/97
Dominique Turck et al.
EFSA JOURNAL (2017)
The Economic Burden of Schizophrenia in the United States in 2013
Martin Cloutier et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Maternal immune activation: Implications for neuropsychiatric disorders
Myka L. Estes et al.
SCIENCE (2016)
Intake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune Activation
Mei Han et al.
SCIENTIFIC REPORTS (2016)
Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation
Yuko Fujita et al.
SCIENTIFIC REPORTS (2016)
Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice
Xingqin Zhou et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Gender differences in first-episode psychosis at 5-year follow-up - two different courses of disease? Results from the OPUS study at 5-year follow-up
A. Thorup et al.
EUROPEAN PSYCHIATRY (2014)
Pyrroloquinoline Quinone Induces Cancer Cell Apoptosis via Mitochondrial-Dependent Pathway and Down-Regulating Cellular Bcl-2 Protein Expression
Zhihui Min et al.
JOURNAL OF CANCER (2014)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Pyrroloquinoline-quinone and its versatile roles in biological processes
H. S. Misra et al.
JOURNAL OF BIOSCIENCES (2012)
Production and Radioprotective Effects of Pyrroloquinoline Quinone
Xiang-Hua Xiong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Prevention of schizophrenia
Ming T. Tsuang et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Pyrroloquinoline Quinone: A Novel Vitamin?
Amy Bishop et al.
NUTRITION REVIEWS (2010)
Prenatal Malnutrition and Adult Schizophrenia: Further Evidence From the 1959-1961 Chinese Famine
Ming-Qing Xu et al.
SCHIZOPHRENIA BULLETIN (2009)
Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats
Kei Ohwada et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2008)
Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes
Rong Tao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis
DO Perkins et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Dermatoglyphics and schizophrenia:: A meta-analysis and investigation of the impact of obstetric complications upon a-b ridge count
E Bramon et al.
SCHIZOPHRENIA RESEARCH (2005)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice
RV de Oliveira et al.
BEHAVIOURAL PHARMACOLOGY (2005)
The neurodevelopmental hypothesis of schizophrenia: a review of recent developments
JJ McGrath et al.
ANNALS OF MEDICINE (2003)
Schizophrenia as a complex trait - Evidence from a meta-analysis of twin studies
PF Sullivan et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Prenatal exposure to famine and brain morphology in schizophrenia
HE Hulshoff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
